Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1858 1
1872 1
1873 1
1876 1
1888 1
1894 1
1902 1
1903 1
1908 1
1911 1
1912 1
1916 1
1918 1
1924 1
1925 1
1932 1
1934 2
1935 3
1936 1
1938 1
1939 2
1940 1
1943 1
1945 5
1946 12
1947 14
1948 13
1949 9
1950 25
1951 34
1952 30
1953 33
1954 32
1955 27
1956 22
1957 34
1958 23
1959 23
1960 28
1961 33
1962 29
1963 27
1964 27
1965 43
1966 35
1967 59
1968 39
1969 52
1970 51
1971 61
1972 74
1973 68
1974 67
1975 178
1976 198
1977 161
1978 159
1979 191
1980 197
1981 224
1982 205
1983 277
1984 342
1985 358
1986 404
1987 430
1988 481
1989 612
1990 678
1991 758
1992 947
1993 1104
1994 1183
1995 1224
1996 1395
1997 1383
1998 1508
1999 1585
2000 1865
2001 2051
2002 2301
2003 2664
2004 2968
2005 3434
2006 3680
2007 3990
2008 4460
2009 4887
2010 5248
2011 5647
2012 5995
2013 6803
2014 7158
2015 7653
2016 7522
2017 7822
2018 8029
2019 8386
2020 9549
2021 10169
2022 9969
2023 10049
2024 4226

Text availability

Article attribute

Article type

Publication date

Search Results

146,806 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: nuramatjan
Page 1
Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study.
Peltier A, van Velthoven R, Baudewyns A, Assenmacher G, Lemort M, Lefebvre Y, Sirtaine N, Diamand R. Peltier A, et al. BJU Int. 2024 May 14. doi: 10.1111/bju.16385. Online ahead of print. BJU Int. 2024. PMID: 38742416
OBJECTIVE: To assess histopathological outcomes, as well as feasibility and safety of targeted microwave ablation (TMA) via the Trinity system (KOELIS, La Tronche, France). ...Conversely, a significant reduction was noted in the surgical specimen (median volume: 0.221 mL). …
OBJECTIVE: To assess histopathological outcomes, as well as feasibility and safety of targeted microwave ablation (TMA) via the Trini …
Metastasectomy and Stereotactic Body Radiotherapy for Colorectal Cancer With Liver and Lung Oligometastases: A Case Report of Complete Remission in a 96-Year-Old Patient.
Pan M. Pan M. Cureus. 2024 Apr 12;16(4):e58135. doi: 10.7759/cureus.58135. eCollection 2024 Apr. Cureus. 2024. PMID: 38741816 Free PMC article.
Soon he was found to have liver metastasis treated with radiofrequency ablation and then liver metastasectomy with clear margins, followed by chemotherapy in the form of FOLFIRI for six months. ...
Soon he was found to have liver metastasis treated with radiofrequency ablation and then liver metastasectomy with clear margins, fol …
Effects of rosiglitazone on quality of life and prognosis of patients with early stage glottic laryngeal carcinoma.
Tu P, Lv Y, Cai L. Tu P, et al. Pak J Pharm Sci. 2024 Jan;37(1):9-15. Pak J Pharm Sci. 2024. PMID: 38741395
The control group received low-temperature plasma radiofrequency ablation and the observation group additionally received rosiglitazone; 4 mg, 2 times/day for 6 months. ...
The control group received low-temperature plasma radiofrequency ablation and the observation group additionally received rosiglitazo …
Intracardiac echocardiography guided anatomical ablation of the arcuate ridge for drug refractory inappropriate sinus tachycardia.
Cabrera JS, Tapias C, Adams C, Hernandez B, Bautista W, Stozitzky V, Restrepo AJ, Saenz L. Cabrera JS, et al. J Cardiovasc Electrophysiol. 2024 May 13. doi: 10.1111/jce.16285. Online ahead of print. J Cardiovasc Electrophysiol. 2024. PMID: 38741382
INTRODUCTION: Inappropriate sinus tachycardia (IST) is a common condition with frequently not tolerated beta-blockers or ivabradine and a high rate of complication in ablation strategy; we describe an alternative anatomical approach of sinus node (SN) modulation. METHODS: …
INTRODUCTION: Inappropriate sinus tachycardia (IST) is a common condition with frequently not tolerated beta-blockers or ivabradine and a hi …
The left atrial appendage closure by surgery 2 trial: statistical analysis plan for a randomized multicenter trial exploring if the closure of the left atrial appendage during open-heart surgery reduces stroke irrespective of patients' stroke risk and preoperative atrial fibrillation status.
Madsen CL, Park-Hansen J, Hadad R, Greve AM, Domínguez H. Madsen CL, et al. Trials. 2024 May 14;25(1):317. doi: 10.1186/s13063-024-08122-9. Trials. 2024. PMID: 38741218
The primary exclusion criteria are planned LAA closure, planned AF ablation, or ongoing endocarditis. Before randomization, a three-step stratification process will sort patients by site, surgery type, and preoperative or expected oral anticoagulation treatment. ...
The primary exclusion criteria are planned LAA closure, planned AF ablation, or ongoing endocarditis. Before randomization, a three-s …
The subcommissural organ regulates brain development via secreted peptides.
Zhang T, Ai D, Wei P, Xu Y, Bi Z, Ma F, Li F, Chen XJ, Zhang Z, Zou X, Guo Z, Zhao Y, Li JL, Ye M, Feng Z, Zhang X, Zheng L, Yu J, Li C, Tu T, Zeng H, Lei J, Zhang H, Hong T, Zhang L, Luo B, Li Z, Xing C, Jia C, Li L, Sun W, Ge WP. Zhang T, et al. Nat Neurosci. 2024 May 13. doi: 10.1038/s41593-024-01639-x. Online ahead of print. Nat Neurosci. 2024. PMID: 38741020
Mouse strains expressing Cre recombinase from endogenous promoter/enhancer elements of these genes were used to genetically ablate SCO cells during embryonic development, resulting in severe hydrocephalus and defects in neuronal migration and development of neuronal axons …
Mouse strains expressing Cre recombinase from endogenous promoter/enhancer elements of these genes were used to genetically ablate SC …
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R, Taniki N, Chu PS, Tamura M, Tabuchi T, Yamaguchi A, Hayatsu S, Koizumi J, Ojiro K, Hoshi H, Kaneko F, Morikawa R, Noguchi F, Yamataka K, Usui S, Ebinuma H, Itano O, Hasegawa Y, Abe Y, Kitago M, Inoue M, Nakatsuka S, Jinzaki M, Kitagawa Y, Kanai T, Nakamoto N. Kasuga R, et al. Sci Rep. 2024 May 13;14(1):10896. doi: 10.1038/s41598-024-61611-4. Sci Rep. 2024. PMID: 38740983
We aimed to identify predictors that define treatment refractoriness against locoregional(transarterial chemoembolization(TACE) or thermal ablation) and surgical therapy. This multicenter retrospective study enrolled 1167 HCC patients between 2015 and 2021. ...
We aimed to identify predictors that define treatment refractoriness against locoregional(transarterial chemoembolization(TACE) or thermal …
Adenosine mediates the amelioration of social novelty deficits during rhythmic light treatment of 16p11.2 deletion female mice.
Ju J, Li X, Pan Y, Du J, Yang X, Men S, Liu B, Zhang Z, Zhong H, Mai J, Wang Y, Hou ST. Ju J, et al. Mol Psychiatry. 2024 May 13. doi: 10.1038/s41380-024-02596-4. Online ahead of print. Mol Psychiatry. 2024. PMID: 38740879
Indeed, either blocking the A(1)R using a specific antagonist DPCPX or knocking down the A(1)R in the PFC using a shRNA completely ablated the beneficial effects of 40 Hz light flicker. Thus, this study identified adenosine as a novel neurochemical mediator for amelioratin …
Indeed, either blocking the A(1)R using a specific antagonist DPCPX or knocking down the A(1)R in the PFC using a shRNA completely ablate
[Arrhythmias and amyloidosis].
Papathanasiou M, Schlender LS, Johnson VL, Wakili R. Papathanasiou M, et al. Herzschrittmacherther Elektrophysiol. 2024 May 13. doi: 10.1007/s00399-024-01016-y. Online ahead of print. Herzschrittmacherther Elektrophysiol. 2024. PMID: 38740607 Review. German.
146,806 results
You have reached the last available page of results. Please see the User Guide for more information.